{
 "url": "https://etfiq.com/funds/idna/holdings/",
 "section": "funds",
 "title": "IDNA Holdings: All 55 Positions (Oct 13, 2026) | ETFIQ",
 "description": "All 55 IDNA holdings with weights, as of Oct 13, 2026. The top 3 are MRNA 13.10%, TWST 6.28% and IOVA 5.07%. Download the full list as a CSV.",
 "as_of": "Oct 13, 2026",
 "ticker": "IDNA",
 "fund": "iShares Genomics Immunology and Healthcare ETF",
 "fund_page": "https://etfiq.com/funds/idna",
 "positions": 55,
 "positions_listed_on_page": 55,
 "lead": "IDNA held 55 positions as of Oct 13, 2026. Moderna is the largest at 13.10%; the top 10 are 49.4% of the fund.",
 "source": {
  "name": "iShares (BlackRock)",
  "url": "https://www.ishares.com/us/products/308878/x/latest-holdings.csv",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-13",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Moderna",
   "ticker": "MRNA",
   "weight_pct": 13.1,
   "page": "https://etfiq.com/holdings/mrna/"
  },
  {
   "rank": 2,
   "holding": "Twist Bioscience",
   "ticker": "TWST",
   "weight_pct": 6.28,
   "page": "https://etfiq.com/holdings/twst/"
  },
  {
   "rank": 3,
   "holding": "Iovance Biotherapeutics Inc",
   "ticker": "IOVA",
   "weight_pct": 5.07,
   "page": "https://etfiq.com/holdings/iova/"
  },
  {
   "rank": 4,
   "holding": "Genmab",
   "ticker": "GMAB",
   "weight_pct": 4.31,
   "page": "https://etfiq.com/holdings/gmab/"
  },
  {
   "rank": 5,
   "holding": "Revolution Medicines",
   "ticker": "RVMD",
   "weight_pct": 3.63,
   "page": "https://etfiq.com/holdings/rvmd/"
  },
  {
   "rank": 6,
   "holding": "Takeda Pharmaceutical",
   "ticker": null,
   "weight_pct": 3.51,
   "page": "https://etfiq.com/holdings/tachem/"
  },
  {
   "rank": 7,
   "holding": "Regeneron Pharmaceuticals",
   "ticker": "REGN",
   "weight_pct": 3.41,
   "page": "https://etfiq.com/holdings/regn/"
  },
  {
   "rank": 8,
   "holding": "Bayer AG",
   "ticker": "BAYN",
   "weight_pct": 3.4,
   "page": "https://etfiq.com/holdings/bayn/"
  },
  {
   "rank": 9,
   "holding": "Merck & Co Inc",
   "ticker": "MRK",
   "weight_pct": 3.38,
   "page": "https://etfiq.com/holdings/mrk/"
  },
  {
   "rank": 10,
   "holding": "Immunitybio",
   "ticker": "IBRX",
   "weight_pct": 3.32,
   "page": null
  },
  {
   "rank": 11,
   "holding": "Caris Life Sciences",
   "ticker": "CAI",
   "weight_pct": 3.26,
   "page": null
  },
  {
   "rank": 12,
   "holding": "Exelixis Inc",
   "ticker": "EXEL",
   "weight_pct": 3.24,
   "page": "https://etfiq.com/holdings/exel/"
  },
  {
   "rank": 13,
   "holding": "Vertex Pharmaceuticals",
   "ticker": "VRTX",
   "weight_pct": 3.12,
   "page": "https://etfiq.com/holdings/vrtx/"
  },
  {
   "rank": 14,
   "holding": "Incyte Corp",
   "ticker": "INCY",
   "weight_pct": 3.05,
   "page": "https://etfiq.com/holdings/incy/"
  },
  {
   "rank": 15,
   "holding": "Roche Ps Par AG",
   "ticker": "ROP",
   "weight_pct": 3.02,
   "page": "https://etfiq.com/holdings/rop-sw/"
  },
  {
   "rank": 16,
   "holding": "Biontech SE ADR",
   "ticker": "BNTX",
   "weight_pct": 2.91,
   "page": null
  },
  {
   "rank": 17,
   "holding": "Abcellera Biologics",
   "ticker": "ABCL",
   "weight_pct": 2.67,
   "page": null
  },
  {
   "rank": 18,
   "holding": "Glaxosmithkline",
   "ticker": "GSK",
   "weight_pct": 2.57,
   "page": null
  },
  {
   "rank": 19,
   "holding": "Ideaya Biosciences",
   "ticker": "IDYA",
   "weight_pct": 2.57,
   "page": "https://etfiq.com/holdings/idya/"
  },
  {
   "rank": 20,
   "holding": "Sanofi SA",
   "ticker": "SAN",
   "weight_pct": 2.53,
   "page": "https://etfiq.com/holdings/san/"
  },
  {
   "rank": 21,
   "holding": "Ipsen SA",
   "ticker": "IPN",
   "weight_pct": 2.52,
   "page": "https://etfiq.com/holdings/ipn/"
  },
  {
   "rank": 22,
   "holding": "Novavax",
   "ticker": "NVAX",
   "weight_pct": 1.81,
   "page": null
  },
  {
   "rank": 23,
   "holding": "Arcus Biosciences",
   "ticker": "RCUS",
   "weight_pct": 1.7,
   "page": "https://etfiq.com/holdings/rcus/"
  },
  {
   "rank": 24,
   "holding": "ONO Pharmaceutical",
   "ticker": null,
   "weight_pct": 1.46,
   "page": "https://etfiq.com/holdings/ono-pharmaceutical-co-ltd/"
  },
  {
   "rank": 25,
   "holding": "Crispr Therapeutics AG",
   "ticker": "CRSP",
   "weight_pct": 1.29,
   "page": "https://etfiq.com/holdings/crsp/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "BLK Csh Fnd Treasury Sl Agency",
   "weight_pct": 0.18
  },
  {
   "holding": "JPY Cash",
   "weight_pct": 0.07
  },
  {
   "holding": "EUR Cash",
   "weight_pct": 0.02
  },
  {
   "holding": "Cash Collateral Usd Hbcft",
   "weight_pct": 0.02
  },
  {
   "holding": "CHF Cash",
   "weight_pct": 0.01
  },
  {
   "holding": "GBP Cash",
   "weight_pct": 0.0
  },
  {
   "holding": "TWD Cash",
   "weight_pct": 0.0
  },
  {
   "holding": "KRW Cash",
   "weight_pct": 0.0
  },
  {
   "holding": "DKK Cash",
   "weight_pct": 0.0
  },
  {
   "holding": "HKD Cash",
   "weight_pct": -0.02
  },
  {
   "holding": "USD Cash",
   "weight_pct": -0.05
  },
  {
   "holding": "Cash and other net assets",
   "weight_pct": -0.01
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/idna/holdings/idna-holdings.csv",
 "json_book": "https://etfiq.com/data/books/idna.json",
 "markdown": "https://etfiq.com/funds/idna/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of IDNA, data as of Oct 13, 2026. https://etfiq.com/funds/idna/holdings/"
}